1 – 27 of 27
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways
(
- Contribution to journal › Article
-
Mark
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
(
- Contribution to journal › Article
-
Mark
Butler enables rapid cloud-based analysis of thousands of human genomes
(
- Contribution to journal › Article
- 2019
-
Mark
How does emerging patent case law in the US and Europe affect precision medicine?
(
- Contribution to journal › Article
- 2017
-
Mark
Ethical principles for the use of human cellular biotechnologies
(
- Contribution to journal › Article
- 2015
-
Mark
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown.
(
- Contribution to journal › Article
-
Mark
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?
(
- Contribution to journal › Article
- 2014
-
Mark
OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data.
(
- Contribution to journal › Article
- 2012
-
Mark
BLUEPRINT to decode the epigenetic signature written in blood
(
- Contribution to journal › Letter
-
Mark
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome
(
- Contribution to journal › Letter
-
Mark
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
(
- Contribution to journal › Article
-
Mark
Dopaminergic neurons for Parkinson's therapy.
(
- Contribution to journal › Article
- 2011
-
Mark
Clarity and claims in variation/mutation databasing.
(
- Contribution to journal › Letter
- 2010
-
Mark
Minimum information about a protein affinity reagent (MIAPAR)
(
- Contribution to journal › Letter
- 2008
-
Mark
Human Proteinpedia enables sharing of human protein data.
(
- Contribution to journal › Letter
-
Mark
What is principal component analysis?
(
- Contribution to journal › Article
- 2007
-
Mark
Ethical framework for previously collected biobank samples
(
- Contribution to journal › Letter
-
Mark
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
(
- Contribution to journal › Article
-
Mark
Bacterial glycosidases for the production of universal red blood cells
(
- Contribution to journal › Article
-
Mark
A human phenome-interactome network of protein complexes implicated in genetic disorders
(
- Contribution to journal › Article
- 2005
-
Mark
The International Stem Cell initiative: toward benchmarks for human embryonic stem cell research
(
- Contribution to journal › Article
- 2003
-
Mark
Recombinant antibody microarrays - a viable option?
(
- Contribution to journal › Letter
-
Mark
Bringing diabetes therapeutics to the big screen.
(
- Contribution to journal › Letter
- 2002
-
Mark
Creating a good impression
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Antibody evolution beyond nature
(
- Contribution to journal › Letter
-
Mark
A DNA prism for high-speed continuous fractionation of large DNA molecules
(
- Contribution to journal › Article
- 2001
-
Mark
Direct delivery of leptin to the hypothalamus using recombinant adeno-associated virus vectors results in increased therapeutic efficacy
(
- Contribution to journal › Article